Mechanisms and prospects of ischemic tolerance induced by cerebral preconditioning
- PMID: 21253330
- PMCID: PMC3021810
- DOI: 10.5213/inj.2010.14.4.203
Mechanisms and prospects of ischemic tolerance induced by cerebral preconditioning
Abstract
In the brain, brief episodes of ischemia induce tolerance against a subsequent severe episode of ischemia. This phenomenon of endogenous neuroprotection is known as preconditioning-induced ischemic tolerance. The purpose of this review is to summarize the current state of knowledge about mechanisms and potential applications of cerebral preconditioning and ischemic tolerance. Articles related to the terms ischemic preconditioning and ischemic tolerance were systematically searched via MEDLINE/PubMed, and articles published in English related to the nervous system were selected and analyzed. The past two decades have provided interesting insights into the molecular mechanisms of this neuroprotective phenomenon. Although both rapid and delayed types of tolerance have been documented in experimental settings, the delayed type has been found to be more prominent in the case of neuronal ischemic tolerance. Many intracellular signaling pathways have been implicated regarding ischemic preconditioning. Most of these are associated with membrane receptors, kinase cascades, and transcription factors. Moreover, ischemic tolerance can be induced by exposing animals or cells to diverse types of endogenous and exogenous stimuli that are not necessarily hypoxic or ischemic in nature. These cross-tolerances raise the hope that, in the future, it will be possible to pharmacologically activate or mimic ischemic tolerance in the human brain. Another promising approach is remote preconditioning in which preconditioning of one organ or system leads to the protection of a different (remote) organ that is difficult to target, such as the brain. The preconditioning strategy and related interventions can confer neuroprotection in experimental ischemia, and, thus, have promise for practical applications in cases of vascular neurosurgery and endo-vascular therapy.
Keywords: Cerebral ischemia; Ischemic tolerance; Pharmacological preconditioning; Preconditioning; Remote preconditioning.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Similar articles
-
Cerebral Ischemic Preconditioning: the Road So Far….Mol Neurobiol. 2016 May;53(4):2579-93. doi: 10.1007/s12035-015-9278-z. Epub 2015 Jun 17. Mol Neurobiol. 2016. PMID: 26081149 Review.
-
Review Cerebral Ischemic Tolerance and Preconditioning: Methods, Mechanisms, Clinical Applications, and Challenges.Front Neurol. 2020 Sep 18;11:812. doi: 10.3389/fneur.2020.00812. eCollection 2020. Front Neurol. 2020. PMID: 33071923 Free PMC article. Review.
-
Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review.J Surg Res. 2008 Dec;150(2):304-30. doi: 10.1016/j.jss.2007.12.747. Epub 2008 Jan 22. J Surg Res. 2008. PMID: 19040966 Review.
-
Clinical application of preconditioning and postconditioning to achieve neuroprotection.Transl Stroke Res. 2013 Feb;4(1):19-24. doi: 10.1007/s12975-012-0224-3. Epub 2012 Nov 15. Transl Stroke Res. 2013. PMID: 24323188 Free PMC article. Review.
-
Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance.J Pharmacol Exp Ther. 2001 May;297(2):474-8. J Pharmacol Exp Ther. 2001. PMID: 11303032 Review.
Cited by
-
Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.Cell Mol Life Sci. 2013 Jul;70(13):2291-303. doi: 10.1007/s00018-012-1167-2. Epub 2012 Sep 27. Cell Mol Life Sci. 2013. PMID: 23014992 Free PMC article. Review.
-
Zinc finger protein 667 expression is upregulated by cerebral ischemic preconditioning and protects cells from oxidative stress.Biomed Rep. 2013 Jul;1(4):534-538. doi: 10.3892/br.2013.124. Epub 2013 May 30. Biomed Rep. 2013. PMID: 24648981 Free PMC article.
-
Function and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment.J Neuroinflammation. 2015 Apr 28;12:80. doi: 10.1186/s12974-015-0301-0. J Neuroinflammation. 2015. PMID: 25928750 Free PMC article. Review.
-
The time course of action of two neuroprotectants, dietary saffron and photobiomodulation, assessed in the rat retina.Am J Neurodegener Dis. 2013 Sep 18;2(3):208-20. eCollection 2013. Am J Neurodegener Dis. 2013. PMID: 24093084 Free PMC article.
-
Oxygen glucose deprivation post-conditioning protects cortical neurons against oxygen-glucose deprivation injury: role of HSP70 and inhibition of apoptosis.J Huazhong Univ Sci Technolog Med Sci. 2014 Feb;34(1):18-22. doi: 10.1007/s11596-014-1225-0. Epub 2014 Feb 6. J Huazhong Univ Sci Technolog Med Sci. 2014. PMID: 24496673
References
-
- American Heart Association. Heart disease and stroke statistics: 2008 update. Dallas: Americna Heart Association; 2008. - PubMed
-
- Grotta J. The current status of neuronal protective therapy: why have all neuronal protective drugs worked in animals but none so far in stroke patients. Cerebrovasc Dis. 1994;4:115–120.
-
- Smith WS. Pathophysiology of focal cerebral ischemia: a therapeutic perspective. J Vasc Interv Radiol. 2004;15(1 Pt 2):S3–S12. - PubMed
-
- Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab. 2002;22:1283–1296. - PubMed
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous